| Oct 31 |
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
|
| Oct 22 |
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
|
| Oct 21 |
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
|
| Sep 19 |
Sonoma Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
|
| Sep 19 |
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
|
| Sep 17 |
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
|
| Sep 11 |
Sonoma and EMC to co-market an expanded eye care product line
|
| Sep 11 |
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
|
| Aug 28 |
Sonoma Pharmaceuticals to implement a reverse stock split
|
| Aug 28 |
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
|
